Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Prostate. 2010 May 1;70(6):675–688. doi: 10.1002/pros.21112

Table I. Quantification of Nuclear Staining Intensity following Overexpression or Knockdown of EZH2.

Endogenous* Expression** Nuclear Staining**
EZH2 EED Ratio EZH2 shEZH2 EZH2 ± SD shEZH2 ± SD

LAPC4 0.060 0.101 0.6 11.0 0.3 1.52 ± 0.35 0.53 ± 0.02
LNCaP 0.032 0.027 1.2 4.3 0.5 1.8 ± 0.04 0.45 ± 0.01
22Rv1 0.066 0.036 1.8 7.0 0.4 1.46 ± 0.14 0.31 ± 0.03
PC3 0.038 0.018 2.1 9.0 0.3 1.35 ± 0.20 0.51 ± 0.15
DU145 0.026 0.047 0.6 5.6 0.8 1.86 ± 0.04 0.69 ± 0.13

EZH2: Overexpression of EZH2, shEZH2: Knockdown of EZH2.

*

Relative to β-Actin;

**

Nuclear staining for H3K27Me3 was quantified in at least two GFP positive cells in each field, quantities shown are fold change over respective controls;

Ratio of EZH2 to EED.